So we decided to take that story a narrative and tell it during the Super Bowl." Modern Health, an X account with 42,000 followers, wrote on the platform: "Serena Williams appears in a Super Bowl advertisement administering a GLP-1 based weight loss medication, broadcast to millions of viewers
Fortunately, GLP1 medications are now FDA-indicated for multiple indications beyond weight management and diabetes, including: Major cardiovascular event (heart attack and/or stroke) risk reduction in adults with cardiovascular disease and overweight or obesity Metabolic dysfunctionassociated steatohepatitis (MASH) Moderate to severe obstructive sleep apnea (OSA) in adults with obesity When one medication can address multiple conditions, it simplifies care and reduces polypharmacy
Clinical Diabetes
A., Gupta, A., Vajifdar, B
Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo
Original price was: $104.76.$64.26Current price is: $64.26